Health
Study shows 90.7% efficacy for the BNT162b2 COVID vaccine in 5-11 year-olds – News-Medical.Net
A new study evaluates the safety, immunogenicity, and efficacy of the BNT162b2 in children who were 5 to 11 years of age.
Vaccination against coronavirus disease 2019 (COVID-19) has been considered to be the most effective way to reduce the mortality and morbidity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Several vaccine candidates have…
Continue Reading
-
Noosa News17 hours agoYoung voices shape Sunshine Coast’s future
-
Business16 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News14 hours agoSudden death investigation, Maroochydore – Sunshine Coast
-
General20 hours agoUS stocks sink further as Donald Trump urges Americans to be ‘courageous and patient’